Trince
![Trince](https://flanders.bio/storage/files/89f6a32f-c145-44e6-8c2c-ded31fd784b5/company_logo-member-trince.jpg)
Ottergemsesteenweg-Zuid 731
9000 Gent
BE
Trince
Foundation date
17/09/2021
Sector
#Supplier & EngineeringSubsector
- #Supplier - Instrumentation
- #Supplier - Laboratory consumables and reagents
- #Supplier - Laboratory equipment
- #Supplier - Medical devices
- #Supplier - Synthetic materials
Trince, a spin-off company from UGent is dedicated to delivering molecules into cells, both in vitro and ex vivo. Its LumiPore transfection platform combines laser exposure and nanoparticles to transiently permeabilize cell membranes. It can be used to deliver a wide variety of effector molecules into virtually any cell type, including hard-to-transfect cells. The high-throughput technology ensures efficient and gentle transfection, maximizing the therapeutic quality of the final cell product.
Upcoming events
All events-
1109 '24
The Leuven Protein Aggregation Meeting (2nd edition)
Event by: VIB -
1010 '24
-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group
Latest news
More news-
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
Tuesday July 16th 2024
Read more
-
ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust
Tuesday July 16th 2024
Read more
-
Ghent University spin-off Trince wins Nature Spinoff Prize
Monday July 15th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator